Stockholm - Delayed Quote SEK
Aptahem AB (publ) (APTA.ST)
1.1500
+0.0100
+(0.88%)
At close: May 28 at 12:54:12 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-13,860
-13,860
-12,615
4,751.1060
-37,214.1070
Investing Cash Flow
-4,093
-4,093
-10,548
-46,924.5830
-478.9820
Financing Cash Flow
19,994
19,994
5,023
16,164.4940
55,370.4490
End Cash Position
4,132
4,132
2,091
20,230.6460
46,239.6290
Capital Expenditure
--
--
-10,548.1990
-46,924.5830
-478.9820
Issuance of Capital Stock
--
--
6,134.3080
17,362.1750
65,338.7560
Free Cash Flow
-13,860
-13,860
-12,615
-42,173.4770
-37,693.0890
12/31/2021 - 4/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NANECH.ST NanoEcho AB
0.1024
+0.59%
LIDDS.ST LIDDS AB (publ)
0.0320
-35.48%
KAN.ST Kancera AB (publ)
1.0120
+1.30%
BIOSGN.ST Biosergen AB
0.5380
+1.51%
ONCO.ST Oncopeptides AB (publ)
1.7720
+0.80%
HNSA.ST Hansa Biopharma AB (publ)
23.30
-1.85%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
23.15
+0.65%
ALLR Allarity Therapeutics, Inc.
0.8916
-3.91%
JUNS Jupiter Neurosciences, Inc.
0.8421
+2.70%
ABP Abpro Holdings, Inc.
0.2330
-9.16%